Drugs / AIDSVAX® B/E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04066881 | Dec 2020 → Dec 2024 | HIV infectious disease | MRC/UVRI and LSHTM Uganda Research Unit | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04066881 ↗ |
| Route | Intramuscular | “1ml of AIDSVAX® B/E will be injected into the deltoid muscle of the right arm” NCT04066881 ↗ |